← Leaderboards
Benjamin M Buehrer
Zen-Bio, Inc.
$5,992,964
Attributed
$7,584,706
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2008–19$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,584,706 · 9
By mechanism
R44$6,025,571 · 4
R43$1,559,135 · 5
Top collaborators
- Sarah A Compton3 shared
- Arno W Tilles2 shared
- Muralikrishna Vemula2 shared
- Martin L Yarmush2 shared
- Heather Lee Hayes1 shared
- John William Ludlow1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseMolecularSmall MoleculeProductionProgramsScreeningReagentLeadIn VitroPharmaceutical PreparationsCommercializationToxic EffectDiabetes MellitusBiological ModelsIn VivoMarketingDesignPhase 1 StudyLibrariesLipid BiosynthesisAgedMalignant NeoplasmsInhibitor/Antagonist
Grant awards (14)
A novel class of anti-acne therapeutics$745,175
R44 · FY2019 · AR
A novel class of anti-acne therapeutics$741,306
R44 · FY2018 · AR
Selective Tuning of Stem Cell Extracellular Vesicles as a Novel Therapy for Age-related Tendinopathy$221,826
R43 · FY2018 · AG · contact PI
A Novel Human Primary Meibomian Gland Cell Platform for Dry Eye Therapeutics$216,626
R43 · FY2018 · AG
A novel class of anti-acne therapeutics$224,999
R43 · FY2016 · AR · contact PI
Development of a drug discovery platform for human islets$682,083
R44 · FY2015 · DK · contact PI
Selective Fyn kinase inhibitors for treatment of metabolic disease$643,364
R44 · FY2015 · DK · contact PI
Development of a drug discovery platform for human islets$1,072,731
R44 · FY2014 · DK · contact PI
Selective Fyn kinase inhibitors for treatment of metabolic disease$855,351
R44 · FY2014 · DK · contact PI
Development of a discovery platform based on microfluidics and fluorescent cell f$339,072
R43 · FY2012 · DK
Commercialization of Human Mammary Basal / Luminal Cell System for Research$603,654
R44 · FY2011 · CA · contact PI
Development of a discovery platform based on microfluidics and fluorescent cell f$349,963
R43 · FY2011 · DK
Commercialization of Human Mammary Basal / Luminal Cell System for Research$681,907
R44 · FY2010 · CA · contact PI
Commercialization of Human Mammary Basal / Luminal Cell System for Research$206,649
R43 · FY2008 · CA · contact PI